Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated

Summary

Article discusses Harmony Biosciences' management performance improvements, noting that the stock has already experienced a re-rating despite these developments. No specific catalysts, financial metrics, or clinical data are provided in the headline.